Response to: 'Belimumab and the measurement of fatigue' by Mazzoni

Vibeke Strand; R. A. Levy; R. Cervera; M. Petri

doi:10.1136/annrheumdis-2015-207700

Response to: 'Belimumab and the measurement of fatigue' by Mazzoni

Vibeke Strand
, R. A. Levy
, R. Cervera
, M. Petri

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	e54
Journal	Annals of the rheumatic diseases
Volume	74
Issue number	9
DOIs	https://doi.org/10.1136/annrheumdis-2015-207700
State	Published - Sep 1 2015

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1136/annrheumdis-2015-207700

Cite this

@article{7e47aeaf9b034aedbd026fe9996c58a2,

title = "Response to: 'Belimumab and the measurement of fatigue' by Mazzoni",

author = "Vibeke Strand and Levy, \{R. A.\} and R. Cervera and M. Petri",

year = "2015",

month = sep,

day = "1",

doi = "10.1136/annrheumdis-2015-207700",

language = "English (US)",

volume = "74",

pages = "e54",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

number = "9",

}

TY - JOUR

T1 - Response to

T2 - 'Belimumab and the measurement of fatigue' by Mazzoni

AU - Strand, Vibeke

AU - Levy, R. A.

AU - Cervera, R.

AU - Petri, M.

PY - 2015/9/1

Y1 - 2015/9/1

UR - https://www.scopus.com/pages/publications/84942109550

UR - https://www.scopus.com/pages/publications/84942109550#tab=citedBy

U2 - 10.1136/annrheumdis-2015-207700

DO - 10.1136/annrheumdis-2015-207700

M3 - Short survey

C2 - 25990291

AN - SCOPUS:84942109550

SN - 0003-4967

VL - 74

SP - e54

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 9

ER -

Response to: 'Belimumab and the measurement of fatigue' by Mazzoni

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this